Description
PROPERTIES
| Quality Level | 200 |
| Mode of action | protein synthesis | interferes |
| antibiotic activity spectrum | mycobacteria |
| originator | Novartis |
| SMILES string | CC(C)\N=C1/C=C2N(c3ccc(Cl)cc3)c4ccccc4N=C2C=C1Nc5ccc(Cl)cc5 |
| InChI | 1S/C27H22Cl2N4/c1-17(2)30-24-16-27-25(15-23(24)31-20-11-7-18(28)8-12-20)32-22-5-3-4-6-26(22)33(27)21-13-9-19(29)10-14-21/h3-17,31H,1-2H3/b30-24+ |
| InChI key | WDQPAMHFFCXSNU-BGABXYSRSA-N |
DESCRIPTION
General description
Clofazimine is a riminophenazine, which is used as an antileprosy drug. It is used to treat multidrug-resistant tuberculosis. Clofazimine prevents neutrophil motility and lymphocyte transformation. It has anti-inflammatory effect, which is used to treat discoid lupus erythematosus. Clofazimine has immunosuppressive property.
Application
Clofazimine has been used:
- for antimicrobial preparation
- to study its accumulation on macrophages to form crystal-like drug inclusions (CLDIs)
- to model drug-induced hepatic granulomatous inflammation
- to study the in vivo cargo storage capacity of macrophages
Packaging
1, 5 g in glass bottle
Features and Benefits
This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
SAFETY INFORMATION
Storage Class Code : 13 – Non Combustible Solids
WGK : WGK 3
Personal Protective Equipment : dust mask type N95 (US), Eyeshields, Gloves
Reviews
There are no reviews yet.